Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies

NCT01760226 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma
Post Transplant Lymphoproliferative Disorder
Primary Mediastinal (Thymic) Large B-cell Lymphoma

Interventions

DRUG: DA-EPOCH-R for DLBCL, PTLD, AND PMBCL
DRUG: Methotrexate
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Prednisone
DRUG: G-CSF

Sponsor

Baylor College of Medicine

Collaborators

[object Object]